Quick Takeaways
- SAPIENT CAPITAL LLC filed SCHEDULE 13G for INTENSITY THERAPEUTICS, INC. Common Stock (INTS).
- Disclosed ownership: 7.4%.
- Date of event: 31 Mar 2024.
SAPIENT CAPITAL LLC - 31 Mar 2024 SCHEDULE 13G Report for INTENSITY THERAPEUTICS, INC. Common Stock (INTS)
- Filing Manager
- SAPIENT CAPITAL LLC
- Reporting Manager
- SAPIENT CAPITAL LLC
- Symbol
- INTS
- Shares outstanding
- 13,676,608 shares
- Disclosed Ownership
- 1,012,069 shares
- Ownership
- 7.4%
- Form type
- SCHEDULE 13G
- Filing time
- 30 Dec 2024, 17:21:53 UTC
- Date of event
- 31 Mar 2024
- Next filing
- 09 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"SAPIENT CAPITAL LLC disclosed 7.4% ownership in INTENSITY THERAPEUTICS, INC. Common Stock (INTS) on 31 Mar 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Dec 2024, 17:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SAPIENT CAPITAL LLC | 7.4% | 1,012,069 | 0 | 0 | MAXIMILIAAN RIJKENBERG | CHIEF COMPLIANCE OFFICER AND CHIEF LEGAL OFFICER |